© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Treatment News
Vaginal Ring Shows Promise as HIV Prevention Tool Women Will Use
IAS 2019
Don’t Miss the Latest News From the IAS Conference on HIV Science
Is It Safe to Interrupt HIV Treatment During Cure Studies?

Good Long-Term Results for Mid-Stage HIV Vaccine Study

The vaccine in the APPROACH study, which led to the Imbokodo and forthcoming Mosaico trails, prompted a robust immune response.

Gilead’s HIV Capsid Inhibitor Worked Well in 1st Human Trial

The investigational, injectable, long-acting antiretroviral is a potential new option for those with multidrug resistance.

Biktarvy Suppresses HIV Well in Women and Those With Drug Resistance

Currently, Gilead Sciences’ HIV regimen is not approved to treat drug-resistant virus.

Peer Recruiters Can Draw Gay Men and Trans Women With HIV Into Care

An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.

Pharmacist-Driven Hep C Treatment Sees Good Cure Rates

Pharmacists oversaw the delivery of hepatitis C treatment in a recent study.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption
a US dollar symbol in a life preserver
Some People With HIV Don’t Adhere to Treatment to Save Money
There’s Never Been a Better Time to Get Pregnant If One of You Has HIV
POZ March 2019 cover U=U Undetectable = Untransmitable
Communicating Undetectable Equals Untransmittable
The Science Is Clear: With HIV, Undetectable Equals Untransmittable
4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Universal HIV “Test and Treat” Linked to Lower Transmission in Botswana

The program was associated with an impressive rise in viral suppression rates.

HIV Linked to Higher Risk for Heart Failure and Stroke

Researchers have sought to pinpoint why HIV doubles cardiovascular disease risk.

Major HIV Vaccine Trial Will Launch in U.S., South America and Europe

The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.

People With HIV Have Good Lung Cancer Surgery Outcomes

HIV-positive people who underwent surgery to remove early lung cancer fared as well as HIV-negative people.

A High Proportion of People With HIV Suffer From Anxiety

Generalized anxiety disorder is associated with lower rates of HIV treatment, adherence to treatment and viral suppression.

Hot topics

#Cure
#Long-Term Survivors
Ounce of Prevention sign against a blue sky
#Prevention
PrEP written on a chalkboard
#PrEP

Starting HIV Treatment Very Early Offers Strong Benefits

A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.

HIV May Persist in the Brain Despite Antiretroviral Treatment

After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.

New Algorithms Could Help Providers ID PrEP Candidates

Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.

HIV Meds Not Tied to Worse Neurodevelopment in HIV-Negative Infants

Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.
Advertisement
Features
Newsfeed

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ